جستجوی استاد راهنمای دانشگاهی

• Geriatrics
• Bone Health
• Osteoporosis
• +۳ مورد دیگر

Shaun M. Chatelain, DO, serves as a Clinical Assistant Professor in the Department of Internal Medicine at the University of Utah School of Medicine, providing specialized geriatric care at Sugarhouse Health Center and Madsen Health Center clinics in Salt Lake City. His academic training includes: Undergraduate: B.S. in Biological Engineering (minor in Chemistry) from Utah State University Medical Degree: Doctor of Osteopathic Medicine from Arizona College of Osteopathic Medicine Residency: Internal Medicine at the University of Arizona Fellowship: Geriatrics at the University of Utah Dr. Chatelain's clinical expertise centers on geriatric medicine with specialized focus on bone health and osteoporosis management , geriatric behavioral health , and deprescribing strategies for polypharmacy . His patient-centered approach emphasizes learning from older adults while optimizing medication regimens to enhance quality of life. His scholarly work (2015-2025) demonstrates consistent contributions to geriatric pharmacotherapy, with recurring themes in medication safety, preoperative assessment for elderly patients, and depression management. Notably, his textbook chapters in Pharmacotherapy: Principles and Practice have established him as a thought leader in evidence-based geriatric care protocols.

Charles J Davidsonمشاهده پروفایل

استاد

• Interventional Cardiology
• Transcatheter Valve Therapy
• Coronary Angioplasty
• +۳ مورد دیگر

Charles J Davidson serves as Professor of Medicine (Cardiology) and Executive Vice Chair for Clinical Affairs at Northwestern University's Feinberg School of Medicine. He maintains clinical appointments at Northwestern Memorial Hospital and Northwestern Medicine Lake Forest Hospital, with expertise in transcatheter valve therapies and coronary interventions. Education: MD: University of Connecticut (1982) Intern: Northwestern University, McGaw Medical Center, Internal Medicine (1983) Resident: Northwestern University, McGaw Medical Center (1985) Fellow: Duke University Medical Center, Cardiology (1988) Dr. Davidson's research focuses on structural heart disease interventions, particularly transcatheter aortic and mitral valve procedures, coronary angioplasty, and diabetic heart complications. His work bridges clinical practice with device innovation through industry collaborations and pivotal trials. His recent publications demonstrate leadership in transcatheter valve replacement outcomes research, with emphasis on TAVR registries, valve-in-valve procedures, and biomarker analysis in asymptomatic aortic stenosis. Key trends include multicenter registry analyses, long-term mortality studies, and complications management in structural heart interventions. Scientific Awards: Physician Clinical Excellence Award for Clinical Collaboration, NMFF (2007) 8 Jacques M. Smith, MD Distinguished Physician in Medicine Awards (2002-2006) Challenging Case Competition 1st Prize, TCT (2004) ACC Basic Research Award (2002) As National Study PI for the CLASP TR Pivotal Trial and Steering Committee member for the Trialign Trial, Dr. Davidson leads major industry-sponsored research. His editorial roles include American Heart Journal and Catheterization and Cardiovascular Interventions, while professional service spans ACGME review committees and AHA session chairmanships. He contributes to the Bluhm Cardiovascular Institute's mission as part of Northwestern's integrated Heart Institutes.

Axel Kriegerمشاهده پروفایل

دانشیار

• Medical Robotics
• Surgical Automation
• Autonomous Surgery
• +۵ مورد دیگر

Dr. Axel Krieger is an Associate Professor of Mechanical Engineering at Johns Hopkins University, with a secondary appointment in Computer Science. He directs the Intelligent Medical Robotic Systems and Equipment (IMERSE) Lab, focusing on autonomous medical robotics, image-guided interventions, and surgical automation. His work includes the Smart Tissue Autonomous Robot (STAR), which achieved milestone autonomous soft-tissue suturing in 2022. Krieger holds over 30 patents, licensed by companies like Intuitive Surgical and Siemens. Education: PhD in Mechanical Engineering, Johns Hopkins University (2008) Masters and Undergraduate Degrees, University of Karlsruhe, Germany Research Interests: Autonomous robotic surgery and smart tool development 3D-printed patient-specific implants Magnetically actuated microsurgery AI-driven surgical planning and control Key Achievements: Developed STAR surgical robot performing unsupervised soft-tissue surgery NSF Early CAREER Award (2022) Over 30 issued/pending patents Labs & Teams: Director of IMERSE Lab Member: Laboratory for Computational Sensing and Robotics (LCSR) Member: Malone Center for Engineering in Healthcare

Greg Adamsonمشاهده پروفایل

استادیار بالینی

• Pediatric Cardiology
• Interventional Cardiology
• Pulmonary Arterial Hypertension
• +۳ مورد دیگر

Greg Adamson is a Clinical Assistant Professor in the Department of Pediatrics - Cardiology at Stanford University School of Medicine and a member of the Maternal & Child Health Research Institute (MCHRI) . He specializes in Interventional Cardiology and Lymphatic Diseases , with clinical expertise in managing conditions like chylothorax and pulmonary arterial hypertension. Medical Education : St. Louis University School of Medicine (2014) Residency : University of California San Francisco (2017) Fellowship : Stanford University Pediatric Cardiology Fellowship (2020) Board Certifications : Pediatrics (2017) and Pediatric Cardiology (2024) Dr. Adamson's research focuses on pediatric pulmonary hypertension , cardiac catheterization protocols , and postoperative chylothorax management . His work includes developing prediction models for early chylothorax detection and evaluating vasopressin's hemodynamic effects in Fontan circulation patients. He has contributed to clinical practice guidelines for progressive pulmonary hypertension in children. His recent publications emphasize procedural efficiency in outpatient cardiac catheterization, valve repair durability in congenital heart disease, and standardized chylothorax algorithms . He utilizes multicenter collaborative frameworks and retrospective cohort analyses , with methodological approaches including logistic regression , Cox proportional hazards modeling , and consensus-building surveys . Key technical areas include lymphatic interventions , hemodynamic monitoring , and predictive analytics in pediatric cardiology. In clinical operations, he investigates same-day discharge criteria for pulmonary hypertension patients and optimal timing for advanced therapies . His work addresses practice variations in chylothorax treatment through quality improvement initiatives , including multidisciplinary algorithm development and ex vivo simulation testing for clinical implementation.

C. Michael Gibsonمشاهده پروفایل

استاد پژوهش

• Interventional Cardiology
• Cardiovascular Research
• Clinical Trials
• +۳ مورد دیگر

C. Michael Gibson, MD is a leading interventional cardiologist, cardiovascular researcher, and educator at Harvard Medical School , where he serves as the Chief Executive Officer of the Baim Institute and PERFUSE Research Institute . These institutes have led over 1,000 studies and 5,500 peer-reviewed publications, including 144 in the New England Journal of Medicine . Key Roles: Director of Coronary Care Unit, Cardiac Catheterization Laboratory Director, Chief of Cardiology, Vice Chairman of Medicine Education: BS, MS, and MD from the University of Chicago (Phi Beta Kappa, AOA), followed by training at Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center Research Focus: Pioneered the open artery and microvasculature hypothesis in heart attacks, developed widely used coronary blood flow measures (TIMI frame count, TIMI myocardial perfusion grade), and leads virtual clinical trials like the HEARTLINE trial of the Apple Watch. Current work includes Factor XI inhibitors (milvexian) and apolipoprotein AI infusions for cardiovascular disease. Scientific Contributions: Over 148,000 citations, 659 publications, and leadership in guidelines like the Bleeding Academic Research Consortium . Notable trials include ANDexanet Alfa for anticoagulant reversal and the PEERLESS study comparing mechanical thrombectomy to thrombolysis in pulmonary embolism. Leadership: FDA Cardiorenal Panel member (2017–2021), founder of WikiDoc.org and ClinicalTrialsResults.org Media Influence: Chief Medical Correspondent for the American College of Cardiology, 435K+ social media followers Scientific Awards: Consistently ranked among the world’s most highly cited authors (Thomson Reuters, 2014–present), 50 Most Influential Voices in Healthcare (Medika Life, 2021), and Boston’s Top Doctors (multiple years).

• Pulmonary Hypertension
• Critical Care Medicine
• Internal Medicine
• +۳ مورد دیگر

Kelly Chin, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Pulmonary and Critical Care Medicine. She serves as Director of Pulmonary Hypertension Research and Medical Director of the Heart Lung Clinic. Board Certified: Pulmonary Medicine, Critical Care Medicine Education: B.S. (University of Texas at Austin), M.D. (UTSW), Fellowship (UC San Diego), M.S. Clinical Sciences (UTSW) Her research focuses on pulmonary hypertension treatment through clinical trials, with expertise in macitentan/tadalafil combinations , selexipag therapy , and biomarker identification . She leads the CIPHER studies for early PH detection and has contributed to treatment algorithms for pulmonary arterial hypertension. Recent work examines real-world drug efficacy in portopulmonary hypertension, right ventricular strain in congenital heart disease, and non-invasive diagnostic methods for chronic thromboembolic PH. Clinical interests also include pregnancy outcomes in PAH patients and ASD-PAH management . Texas Monthly's Super Doctor D Magazine's Top Doctors As principal investigator in multiple phase II-IV trials, she explores long-term survival in chronic thromboembolic PH and biomarker signatures for early detection. Her leadership roles include former Director of UTSW Pulmonary Hypertension Program (2010-2023).

• Structural Heart Disease
• Transcatheter Valve Therapy
• Interventional Cardiology
• +۲ مورد دیگر

Dr. Jubin P Joseph is a Clinical Assistant Professor of Medicine at the Keck School of Medicine of the University of Southern California and serves as Director of Structural Interventions in the Cardiac & Vascular Institute. An interventional cardiologist specializing in structural heart disease, he leads advanced transcatheter valve therapies and clinical research initiatives at USC. His educational journey includes: Undergraduate studies at Cambridge University (2005) Medical degree from Oxford University (2008) Internal medicine and cardiology training in England PhD in invasive physiology research from St Thomas' Hospital, London Advanced structural intervention fellowship at Oxford University Hospitals Specialized training at Cedars-Sinai Medical Center (2020-2022) Dr. Joseph's research centers on structural heart disease mechanisms and transcatheter interventions, with particular focus on valve pathophysiology, hemodynamic assessments, and device innovation. His clinical expertise spans transcatheter aortic/mitral/tricuspid valve replacements, MitraClip procedures, left atrial appendage occlusion, and congenital defect closures. He integrates cardiovascular physiology with structural interventions to optimize patient outcomes in complex valve disease. His publication record reveals consistent advancement in transcatheter valve therapy, emphasizing hemodynamic outcomes, imaging guidance, and novel device applications. Recent work demonstrates leadership in TAVR optimization, mitral repair techniques, and physiological assessment during interventions, reflecting his dual commitment to clinical innovation and scientific rigor. Major recognitions include: Peel and Rothwell Jackson Postgraduate Fellowship (2020-2021) European Society of Cardiology's Cardiologist of Tomorrow (2014-2017) Royal College of Surgeons' Preiskel Prize (2008) Multiple medical education travel awards (2008) Cambridge University's Preparing for Patients Prize (2003) As a clinical investigator, Dr. Joseph actively contributes to national multicenter trials while directing structural interventions at USC's Cardiac & Vascular Institute. His team pioneers emerging transcatheter therapies through rigorous physiological assessment and device evaluation, with ongoing research in microvascular dysfunction and next-generation valve technologies. The structural interventions program under his leadership focuses on complex valve disease management, combining cutting-edge transcatheter approaches with comprehensive physiological evaluation to advance structural heart care.

• Cardiovascular Medicine
• Coronary Microvascular Dysfunction
• Myocardial Infarction Pathophysiology
• +۳ مورد دیگر

Dr. Stuart Hood is an Honorary Senior Lecturer at the University of Glasgow, affiliated with the School of Cardiovascular & Metabolic Health and the Cardiology Department at the Royal Alexandra Hospital. His expertise focuses on coronary microvascular dysfunction, myocardial infarction pathophysiology, and interventional cardiology. He has contributed to numerous studies on fractional flow reserve (FFR), stent optimization, and coronary artery disease management. Research interests include the interplay between coronary microvascular function and atherosclerosis, as well as outcomes in patients with non-obstructive coronary arteries. His work integrates clinical trials (e.g., CorMicA, TARGET-FFR) and imaging techniques (e.g., MRI, cardiac CT) to improve diagnostic accuracy and patient care. Key themes in his publications address post-percutaneous coronary intervention (PCI) outcomes, risk stratification in acute myocardial infarction, and the role of systemic microvascular dysfunction in angina. His articles highlight advancements in PCI optimization, prognostic biomarkers for myocardial infarction, and the impact of diabetes on coronary thrombus formation. Dr. Hood collaborates with institutions like the British Cardiovascular Intervention Society and has presented at major conferences such as ACC.18 and the British Society of Cardiovascular Magnetic Resonance. No scientific awards or grants are explicitly listed in the provided materials. His academic contributions are centered on clinical research and translational cardiology, with a focus on improving therapeutic strategies for coronary artery disease and post-infarction care.

Veronica Iacovacciمشاهده پروفایل

استادیار

• Medical Microrobotics
• Implantable Devices
• Targeted Drug Delivery
• +۴ مورد دیگر

Veronica Iacovacci serves as Assistant Professor at Sant'Anna School of Advanced Studies' BioRobotics Institute, where she heads the Medical Microrobotics Lab and leads the I-BOT project developing implantable microrobots for clinical applications. Her academic foundation includes a PhD in BioRobotics (2017, Scuola Superiore Sant'Anna) focusing on magnetic microsystems for targeted therapy, and a combined BSc/MSc in Biomedical Engineering (2013, University of Pisa) with research on mechatronic implantable systems. Her research pioneers medical microrobotics for therapeutic interventions, specializing in programmable magnetic structures, high-resolution imaging/tracking, and wireless activation at micro-scales. Key innovations include ingestible capsule-based refilling systems for implantable devices and magnetic microrobots for targeted drug delivery in restrictive biological environments. Recent publications demonstrate a clear trajectory toward clinical translation, with dominant themes in magnetic actuation control, ultrasound-based microrobot tracking, and refillable implantable systems using ingestible capsules – bridging robotics, materials science, and clinical medicine. Her scientific recognition includes: Big On Small Award 2024 IEIIT CNR 2017 Best PhD Thesis Award in Bioengineering Zeno Karl Schind Scholarship for magnetic microrobot research Euspen 2014 Best Oral Presentation Award Gruppo Nazionale di Bioingeneria 2013 Best MSc Thesis Award She secured significant funding including a Marie Curie Global Fellowship (2020-2023) for the MAMBO project on magnetic swarms for liver chemoembolization, and currently directs the I-BOT project. Her lab integrates robotics, clinical imaging, and materials science to advance microrobotics toward human applications.

Ramez N Abdallaمشاهده پروفایل

استادیار

• Endovascular Neurovascular Surgery
• Cerebrovascular Diseases
• Stroke Intervention
• +۵ مورد دیگر

Ramez N Abdalla, MD, PhD, is an Assistant Professor of Radiology specializing in Interventional Neuroradiology at Northwestern University's Feinberg School of Medicine. His clinical focus includes endovascular management of cerebrovascular diseases, spinal interventions, and acute stroke treatment. He completed his MD, MS, and PhD at Ain Shams University, followed by postgraduate training in Egypt and fellowships at Northwestern University in Interventional Neuroradiology. Dr. Abdalla’s research emphasizes advanced imaging techniques (e.g., 4D Flow MRI) for optimizing stroke care, hemodynamic analysis in intracranial atherosclerosis, and novel treatments for cerebral vasospasm. Education: MD: Ain Shams University, Egypt (2010) MS: Ain Shams University (2015) PhD: Ain Shams University (2023) Fellowships: Ain Shams University (2018–2022) and Northwestern University (2019–2022) Research Interests: Endovascular treatment of neurovascular diseases 4D Flow MRI for cerebrovascular hemodynamics Stroke intervention outcomes Imaging biomarkers for intracranial atherosclerosis Publications reflect his focus on neurovascular imaging and clinical trials comparing endovascular vs. surgical treatments. Notable awards include the 2019 LINNC Travel Grant and Egyptian Ministry research scholarships. He is an active member of societies like the American Society of Neuroradiology and Society of Neurointerventional Surgery. Grants and Collaborations: His work is supported by institutional and registry-based research (e.g., NVQI-QOD). He has contributed to multi-institutional studies on stroke thrombectomy outcomes and ARUBA-eligible AVM treatments. No external industry relationships were disclosed for 2024. Labs/Teams: Collaborates with neurovascular imaging and interventional research groups at Northwestern, focusing on translational applications of advanced MRI and AI-driven diagnostic tools.

• Nursing
• Patient-Centered Care
• Health Sciences
• +۳ مورد دیگر

Emine Korkmaz is a Lecturer at the Faculty of Health Sciences, Department of Nursing at Ahi Evran University , Turkey. She holds a PhD in Nursing from Erciyes University (2022) and master’s degrees from Cumhuriyet University (2017) and Atatürk University (2014). Her research focuses on patient-centered care, virtual reality applications in nursing, pain management, infection control, and healthcare ethics . PhD: Nursing, Erciyes University (2018-2022) Master’s: Nursing, Cumhuriyet University (2014-2017) Master’s: Nursing, Atatürk University (2012-2014) Her recent work explores virtual reality for chemotherapy anxiety , music therapy for bone marrow biopsy patients , and stethoscope disinfection practices . She has contributed to studies on compassion fatigue , vascular complications post-cardiac catheterization , and hemodialysis patient care . Collaborations include researchers like Seda Şahan and Sevil Güler . No scientific awards or part-time roles are documented.

David Kepplingerمشاهده پروفایل

استادیار

• Robust statistics for high-dimensional data
• Regularized estimation and feature selection
• Computational statistics
• +۴ مورد دیگر

David Kepplinger is an Assistant Professor in the Department of Statistics at George Mason University's School of Computing. His academic expertise spans robust statistical methods for high-dimensional data, computational statistics, and applications in biomedical sciences and environmental modeling. Education: PhD in Statistics, University of British Columbia, 2020 Master of Science in Statistics, Vienna University of Technology (Austria) Dr. Kepplinger's research primarily focuses on robust estimation in high-dimensional settings, with particular interest in the robustness of feature selection in the presence of arbitrary contamination and countering the effects of contamination on predictive models. His work addresses critical challenges in statistical analysis where outliers and unusual values can severely impact results, especially in settings with many variables. He develops methods that maintain reliable performance even when data contains contamination in both response variables and explanatory features. His recent publications demonstrate a strong interdisciplinary approach, spanning computational statistics, biomedical applications, environmental modeling, and clinical research. The research shows a consistent theme of developing robust statistical methodologies applicable to complex real-world problems across multiple domains, from protein biomarker identification to phenological modeling of cherry blossom predictions. His work frequently involves developing computational algorithms that can handle non-convex optimization problems common in robust statistics. Dr. Kepplinger serves as a co-organizer for the statistics seminar series and is the PR & communications contact for the Department of Statistics at George Mason University. He mentors PhD students Yang Long and Siqi Wei, who focus on improving computational methods for robust regularized regression estimators. He teaches several courses including STAT 665 (Categorical Data Analysis) and STAT 778 (Statistical Computing). He leads several notable projects including the First International Cherry Blossom Prediction Competition, which has been featured in prominent media outlets like The Weather Network, CBC Radio, and Public Radio's The World. This citizen science initiative aims to improve phenological modeling through crowd-sourced predictions of cherry blossom peak bloom dates in Washington, D.C., Vancouver, Kyoto, and Liestal-Weideli, Switzerland. He also develops multiple R packages available on CRAN and Bioconductor, including pense for robust regression estimation and examinr for creating online exams from R markdown documents.

• Cardiology
• Cardiovascular Disease
• Interventional Cardiology
• +۴ مورد دیگر

Dr. Peter McCartney is an Honorary Clinical Fellow at the School of Cardiovascular & Metabolic Health, University of Glasgow. His research focuses on coronary artery disease, myocardial infarction, and interventional cardiology, with particular expertise in coronary microvascular function and percutaneous coronary intervention (PCI) optimization. He has contributed to landmark trials like CorMicA and T-TIME, investigating stratified medical therapy and adjunctive therapies in cardiovascular conditions. His work spans clinical trials, systematic reviews, and meta-analyses, addressing topics such as coronary perforation management, stent optimization, and microvascular injury assessment. McCartney collaborates widely, including with colleagues at the University of Glasgow and international institutions, to advance diagnostic and therapeutic strategies in cardiovascular medicine. No scientific awards are explicitly mentioned in the provided materials. His publications emphasize patient outcomes, procedural improvements, and invasive coronary function testing. He has been involved in designing trials evaluating therapies like mineralocorticoid receptor antagonists and low-dose intracoronary alteplase. No specific grants or lab affiliations are detailed in the text.

• Atrial Fibrillation
• Cardiac Arrhythmias
• Catheter Ablation
• +۳ مورد دیگر

Domenico Giovanni Della Rocca is a **Visiting Professor** at the **Vrije Universiteit Brussel (VUB)**, affiliated with the **Faculty of Medicine** and the **Department of Cardiovascular Diseases**. He holds clinical roles as a **Physician** specializing in **Heart Rhythm Management** at the Universitair Ziekenhuis Brussel (UZ Brussel). His research focuses on **atrial fibrillation ablation techniques**, **cardiac arrhythmias**, and **Brugada Syndrome diagnosis**, with over 150 peer-reviewed publications since 2021. Key research interests include **catheter-based interventions**, **hybrid surgical-ablation procedures**, and **novel diagnostic tools for cardiac channelopathies**. He has pioneered the use of **pulsed field ablation** and **speckle-tracking echocardiography** in clinical practice. In 2023, he received the **Paul Dudley White International Scholar Award** for contributions to cardiovascular research. Academic Affiliations: VUB (Visiting Professor), UZ Brussel (Physician) Research Outputs:** 154 publications (2021-2025), 709 citations, h-index 14 Collaborations:** Multicenter trials in Europe and international electrophysiology networks His recent work emphasizes **minimally invasive cardiac procedures** and **novel catheter technologies**, with a focus on improving outcomes for patients with complex arrhythmias. Active in professional societies and serves as a reviewer for journals like *Heart Rhythm* and *Europace*.

• Molecular Cardiology
• Clinical Cardiology
• Genetics of Coronary Artery Disease
• +۳ مورد دیگر

Anthony White is an Associate Professor at Monash University's Faculty of Medicine, Nursing and Health Sciences, serving as academic co-director of the Clinical Years of the Medical Degree. He holds an external position as a Cardiologist at the Victorian Heart Hospital since 2010. His research integrates molecular biology with clinical cardiology, focusing on coronary artery disease mechanisms, stem cell therapies, and genetic determinants of cardiovascular conditions. He has led three NHMRC-funded projects exploring cardiac stem cells and miRNA roles in cardiomyocyte specification. Education: MBBS from University of Melbourne (1996) and a PhD in Biomechanical, Biochemical and Genetic Determinants of Unstable Coronary Disease. Research Interests Spontaneous coronary artery dissection (SCAD) genetics (F11R gene) Pluripotent stem cells and cardiac tissue regeneration CRISPR-based DNA editing applications Coronary plaque instability mechanisms Cardiac regeneration via organoids and stem cell therapies Advising & Grants Supervised 4 students (2 BMedSc(Hons), 1 Science Honours, 1 PhD). Principal Investigator on projects totaling over AUD 1M including NHMRC grants (2008-2013) and Collier Charitable Fund (2011). Labs/Teams Associated with Victorian Heart Institute and Monash University's Cardiovascular Research Group.